CMP Pharma announced today that in order to mitigate drug shortage concerns, the FDA's CDER Office of Compliance has granted a shelf life extension for CMP Development LLC Potassium

Athos Therapeutics, Inc. a clinical-stage biotechnology company pioneering the development of artificial intelligence-based precision small molecule therapeutics for patients with autoimmune

Medical technology company Scivita Medical Technology Co., Ltd. and Boston Scientific one of the leading medical technology companies worldwide, have officially signed a Strategic Agreement

Astellas Pharma Inc. today announced that it has entered into an agreement with Roche Diabetes Care Japan Co., Ltd. for the development and commercialization of Roche Diabetes Care's

Celularity Inc. a biotechnology company developing placental-derived allogenic cell therapies and biomaterial products announces that it has entered into an exclusive distribution agreement

Aadi Bioscience, Inc. a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR

Pherecydes Pharma a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announces that it has been selected for the 2023

Mitsubishi Tanabe Pharma America, Inc. today announced it has completed enrollment for the global, multi-center, double-blind, Phase 3b study evaluating the long-term efficacy and safety

FSD Pharma Inc. a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory

TaiGen Biotechnology Company, Limited today announces that they have signed an exclusive licensing agreement with Joincare Pharmaceutical Group Industry Co., Ltd., a top 10 China